Inhibition of CD28-mediated natural cytotoxicity by KIR2DL2 does not require p56lck in the NK cell line YT-Indy

Molecular Immunology

Volumn 38, Issue 7, 2002, Pages 495-503

  Tarazona, Raquel ^a   Borrego, Francisco ^b   Galiani, Maria D ^a   Aguado, Enrique ^a   Peña, Jose ^a   Coligan, John E ^b   Solana, Rafael ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

HLA recognition; Killer immunoglobulin like receptor; PLC 1; Src kinases

Indexed keywords

CD28 ANTIGEN; HLA ANTIBODY; HLA CW3 ANTIGEN; LIGAND; MONOCLONAL ANTIBODY; PERVANADATE; PROTEIN; PROTEIN C143; PROTEIN P56; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CROSS LINKING; DEPHOSPHORYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TARGET CELL;

ANTIGENS, CD28; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; JURKAT CELLS; KILLER CELLS, NATURAL; LIGANDS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 0036138202     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(01)00092-X     Document Type: Article

References (60)

1. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line
2. Human natural killer cell activating receptors
3. Sequential involvement of lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation
4. Signal transduction by human NK cell MHC-recognizing receptors
5. SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors
6. Recognition of human histocompatibility leukocyte antigen HLA-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
7. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor
8. HLA-E binds to natural killer cell receptors CD94/NKG2A B and C
9. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor
10. Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses
11. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor
12. lck via cysteine residues
13. Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-γ/δ stimulated by non-peptidic ligands
14. CD28 and the tyrosine kinase lck stimulate mitogen-activated protein kinase activity in T cells via inhibition of the small G protein rap1
15. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules
16. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: Evidence for receptor function in heterologous transfectants
17. Reconstitution of killer cell inhibitory receptor-mediated signal transduction machinery in a cell-free model system
18. Natural killer cell receptors specific for MHC class I molecules
19. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells
20. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles
21. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function
22. Expression of a variant of CD28 on a subpopulation of human NK cells: Implications for B7-mediated stimulation of NK cells
23. Efficient CD28 signalling leads to increases in the kinase activities of the TEC family tyrosine kinase EMT/ITK/TSK and the src family tyrosine kinase lck
24. Proline residues in CD28 and the src homology (SH)3 domain of lck are required for T cell co-stimulation
25. Involvement of protein kinase C-δ in CD28-triggered cytotoxicity mediated by a human leukaemic cell line YT
26. Absence of B7.1-CD28/CTLA-4-mediated co-stimulation in human NK cells
27. NK cell receptors
28. Turning on natural killer cells
29. Inhibitory MHC class I receptors on NK cells and T cells
30. Arousal and inhibition of human NK cells
31. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits
32. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
33. TCR α,β-independent CD28 signaling and co-stimulation require non-CD4-associated lck
34. Natural killer cell receptors
35. CD28-dependent killing by human YT cells requires phosphatidylinositol 3-kinase activation
36. Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones
37. Expression of the CD80 and CD86 molecules enhances cytotoxicity by human natural killer cells
38. Upregulation of B7 molecules by the Epstein-Barr virus enhances susceptibility to lysis by a human NK-like cell line
39. HLA class I specific inhibitory receptors
40. Receptors for HLA class I molecules in human natural killer cells
41. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes
42. Natural cytotoxicity receptors that trigger human NK cell-mediated cytolysis
43. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases
44. CD94/NKG2-A inhibitory complex blocks CD16-triggered syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells
45. Superantigen-dependent cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes
46. Fc-γ RIIIA-mediated signaling involves src-family lck in human natural killer cells
47. HLA-E is the ligand for the natural killer cell CD94/NKG2 receptors
48. Human NK cells: Their ligands receptors and functions
49. Human natural killer cell committed thymocytes and their relation to the T cell lineage
50. CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28
51. HLA-B2702 (77-83/83-77) peptide binds to {β}-tubulin on human NK cells and blocks their cytotoxic capacity
52. CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase and protein kinase C
53. Fc-γ receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-γ1 and PLC-γ2 in natural killer cells
54. Interaction between lck and syk family tyrosine kinases in Fc-γ receptor-initiated activation of natural killer cells
55. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-γ signaling complex in human natural killer (NK) cells
56. Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells
57. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244)
58. NK cell triggering by the human costimulatory molecules CD80 and CD86
59. Tec kinase is involved in transcriptional regulation of IL-2 and IL-4 in the CD28 pathway
60. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells)